Hammerco Lawyers has filed a class action lawsuit on behalf of Canadian residents in light of Health Canada’s drug recall advisory on March 9.
Multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA).
NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer.
Please contact Kevin McLaren if you think you may have been affected by the Losartan drug recall.
More News & Resources
February 24, 2023
Hammerco Lawyers is partnering with Toronto law firm KND Complex Litigation on a potential class action lawsuit against GoTo Technologies USA, Inc. and related companies.
February 15, 2023
We’ve redesigned our navigation and site menu with you in mind. Now, it’s easier to find information about the services we offer and how we can support you to achieve positive legal outcomes.
February 15, 2023
Stressed about the idea of going to court? There may be another way.
January 3, 2023
Join us in congratulating Alexia Majidi on becoming Hammerco Lawyers’ newest partner.